Hormon-Profil Frau (Female Hormones)

A targeted female hormone panel measuring oestradiol (E2), progesterone, LH (luteinising hormone), FSH (follicle-stimulating hormone), prolactin, and DHEA-S. This combination evaluates ovarian function, menstrual cycle regularity, menopausal status, and adrenal androgen output. The panel is timed to cycle day 3 to 5 for premenopausal women to capture baseline follicular phase values.

Female reproductive and metabolic health is governed by a tightly coordinated interplay of hormones that fluctuate throughout the menstrual cycle and shift dramatically during perimenopause and menopause. This panel captures the key players: FSH and LH from the pituitary drive ovarian function, oestradiol and progesterone reflect ovarian output, prolactin screens for pituitary dysfunction, and DHEA-S assesses adrenal androgen production. For premenopausal women, the panel should ideally be drawn on cycle day 3 to 5, when FSH and LH are at baseline levels and oestradiol reflects the resting state of the ovaries. Elevated FSH relative to LH suggests diminished ovarian reserve, a finding relevant for fertility planning. The FSH-to-LH ratio also helps differentiate polycystic ovary syndrome (where LH is disproportionately elevated) from premature ovarian insufficiency. For women in perimenopause or menopause, this panel quantifies the hormonal transition: rising FSH, declining oestradiol, and absent progesterone confirm menopausal status and guide decisions about hormone replacement therapy. DHEA-S provides insight into adrenal function, which becomes the primary source of androgen precursors after ovarian function declines. Results from SYNLAB München Zentrum are typically available within two to three working days.